Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROCAINAMIDE Cause Maternal exposure during pregnancy? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Maternal exposure during pregnancy have been filed in association with PROCAINAMIDE (Procainamide Hydrochloride). This represents 7.9% of all adverse event reports for PROCAINAMIDE.

18
Reports of Maternal exposure during pregnancy with PROCAINAMIDE
7.9%
of all PROCAINAMIDE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Maternal exposure during pregnancy From PROCAINAMIDE?

Of the 18 reports.

Is Maternal exposure during pregnancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROCAINAMIDE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does PROCAINAMIDE Cause?

Drug ineffective (93) Drug hypersensitivity (28) Systemic lupus erythematosus (22) Off label use (21) Atrial fibrillation (18) Electrocardiogram qt prolonged (18) Antiphospholipid syndrome (17) Arthritis (17) Ascites (17) Cardiac tamponade (17)

What Other Drugs Cause Maternal exposure during pregnancy?

CERTOLIZUMAB PEGOL (9,013) ADALIMUMAB (7,518) PREDNISONE (6,587) METHOTREXATE (6,223) RITUXIMAB (6,093) INFLIXIMAB (6,061) HYDROXYCHLOROQUINE (5,809) FOLIC ACID (5,768) TOCILIZUMAB (5,737) LEFLUNOMIDE (5,643)

Which PROCAINAMIDE Alternatives Have Lower Maternal exposure during pregnancy Risk?

PROCAINAMIDE vs PROCAINE PROCAINAMIDE vs PROCARBAZINE PROCAINAMIDE vs PROCHLORPERAZINE PROCAINAMIDE vs PROCHLORPERAZINE EDISYLATE PROCAINAMIDE vs PROCRIT

Related Pages

PROCAINAMIDE Full Profile All Maternal exposure during pregnancy Reports All Drugs Causing Maternal exposure during pregnancy PROCAINAMIDE Demographics